| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 4, 2021Virtual Press Office and PR Newswire: General Trade show news
Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the...
-
Nov 4, 2021Virtual Press Office and PR Newswire: General Trade show news
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for patients with unmet needs, today announced multiple...
-
Nov 4, 2021Virtual Press Office and PR Newswire: General Trade show news
A news report by China.org.cn on art, design and technology: A conference held by China's Tsinghua University last weekend gathered top international artists and designers to explore the future of...
-
Nov 4, 2021Virtual Press Office and PR Newswire: General Trade show news
Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company primarily focused on targeting virus-associated malignancies, today announced the acceptance of two abstracts for oral...
-
Nov 4, 2021Virtual Press Office and PR Newswire: General Trade show news
Lemzoparlimab is a differentiated CD47 monoclonal antibody discovered by I-Mab and being developed in collaboration with AbbVie Initial clinical results of lemzoparlimab in combination with...
